Proteochemometric analysis of small cyclic peptides' interaction with wild-type and chimeric melanocortin receptors

Proteins: Structure, Function and Genetics

Volumn 69, Issue 1, 2007, Pages 83-96

  Kontijevskis, Aleksejs ^a   Petrovska, Ramona ^a   Mutule, Ilze ^a   Uhlen, Staffan ^a,b   Komorowski, Jan ^a   Prusis, Peteris ^a   Wikberg, Jarl E S ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF BERGEN   (Norway)

^c Pharmaceutical Pharmacology   (Sweden)

Author keywords

G protein coupled receptors; HS peptides; Melanocortin receptors; Multipart chimeric receptors; Proteochemometrics; Recognition site; Selectivity

Indexed keywords

G PROTEIN COUPLED RECEPTOR; HS 129 PEPTIDE; HS 130 PEPTIDE; HS 131 PEPTIDE; HS 132 PEPTIDE; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; PENTAPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOINFORMATICS; CACHEXIA; CHEMOMETRICS; CHIMERA; CONTROLLED STUDY; NONHUMAN; OBESITY; PEPTIDE ANALYSIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN INTERACTION;

AMINO ACID SEQUENCE; BINDING SITES; COMPUTATIONAL BIOLOGY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOCORTINS; MOLECULAR SEQUENCE DATA; PEPTIDES, CYCLIC; RECEPTORS, MELANOCORTIN; RECOMBINANT FUSION PROTEINS; REPRODUCIBILITY OF RESULTS;

AGOUTI;

EID: 34548329632     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21461     Document Type: Article

References (35)

1. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Yowchik RP, Wilkison WO, Cone RD. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994;371:799-802.
2. Ollmann MM, Wilson BD, Yang Y-K, Kerns JA, Chen Y, Gantz I, Barsh GS. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997;278:135-138.
3. Nickolls SA, Cismowski MI, Wang X, Wolff M, Conlon PJ, Maki RA. Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity. J Pharmacol Exp Ther 2003;304:1217-1227.
4. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994;8:1298-1308.
5. Wikberg JE, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, Skottner A. New aspects on the melanocortins and their receptors. Pharmacol Res 2000;42:393-420.
6. Wikberg JES. Melanocortin receptors: perspectives for novel drugs. Eur J Pharmacol 1999;375:295-310.
7. Prusis P, Uhlen S, Petrovska R, Lapinsh M, Wikberg JES. Prediction of indirect interactions in proteins. BMC Bioinformatics 2006;7:167.
8. Schiöth HB, Kask A, Mutulis F, Muceniece R, Mutule I, Mutule I, Mandrika I, Wikberg JE. Novel selective melanocortin 4 receptor antagonist induces food intake after peripheral administration. Biochem Biophys Research Commun 2003;301:399-405.
9. Kask A, Mutulis F, Muceniece R, Pahkla R, Mutule I, Wikberg JE, Rago L, Schioth HB. Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo. Endocrinology 1998;139:5006-5014.
10. Lapinsh M, Prusis P, Gutcaits A, Lundstedt T, Wikberg JE. Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions. Biochim Biophys Acta 2001;1525:180-190.
11. Lapinsh M, Prusis P, Lundstedt T, Wikberg JE. Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. Mol Pharmacol 2002;61:1465-1475.
12. Lapinsh M, Prusis P, Mutule I, Mutulis F, Wikberg JE. QSAR and proteo-chemometric analysis of the interaction of a series of organic compounds with melanocortin receptor subtypes. J Med Chem 2003;46:2572-2579.
13. Prusis P, Lundstedt T, Wikberg JES. Proteo-chemometrics analysis of MSH peptide binding to melanocortin receptors. Protein Eng 2002;15:305-311.
14. Wikberg JE, Mutulis F, Mutule I, Veiksina S, Lapinsh M, Petrovska R, Prusis P. Melanocortin receptors: ligands and proteochemometrics modeling. Ann NY Acad Sci 2003;994:21-26.
15. Wikberg JES, Lapinsh M, Prusis P. Proteochemometrics: a tool for modeling the molecular interaction space. In: Kubinyi H, Müller G, Mannhold R, Folkers G, editors. Chemogenomics in drug discovery - a medicinal chemistry perspective. Weinheim: Wiley-VCH; 2004. pp 289-309.
16. Chhajlani V, Wikberg JE. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 1992;309:417-420.
17. Chhajlani V, Muceniece R, Wikberg JE. Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun 1993;195:866-873.
18. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 1993;268:15174-15179.
19. Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SJ, DelValle J, Yamada T. Molecular cloning of a novel melanocortin receptor. J Biol Chem 1993;268:8246-8250.
20. Lapinsh M, Veiksina S, Uhlen S, Petrovska R, Mutule I, Mutulis F, Yahorava S, Prusis P, Wikberg JES. Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes. Mol Pharm 2005;67:50-59.
21. Schiöth HB, Muceniece R, Wikberg JE. Characterisation of the melanocortin 4 receptor by radioligand binding. Pharmacol Toxicol 1996;79:161-165.
22. Schiöth HB, Muceniece R, Wikberg JE, Chhajlani V. Characterisation of melanocortin receptor subtypes by radioligand binding analysis. Eur J Pharmacol 1995;288:311-317.
23. Horn F, Bettler E, Oliveira L, Campagne F, Cohen FE, Vriend G. GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res 2003;31:294-297.
24. Sandberg M, Eriksson L, Jonsson J, Sjöström M, Wold S. New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. J Med Chem 1998;41:2481-2491.
25. Wold S, Esbensen K, Geladi P. Principal component analysis. Chemometr Intell Lab Syst 1987;2:37-52.
26. SIMCA-P 10.0 user guide and tutorial. Umeå: Umetrics AB; 2002.
27. Geladi P, Kowalski BR. Partial least-squares regression: a tutorial. Anal Chim Acta 1986;185:1-17.
28. Wold S. Cross-validatory estimation of the number of components in factor and principal component models. Technometrics 1978;20:397-405.
29. Wakeling IN, Morris JJ. A test of significance for partial least squares regression. J Chemometr 1993;7:291-304.
30. Efron B. Better bootstrap confidence intervals. J Am Stat Assoc 1987;78:171-200.
31. Box GEP, Muller ME. A note on the generation of random normal deviates. Ann Math Stat 1958;29:610-611.
32. Prusis P, Muceniece R, Andersson P, Post C, Lundstedt T, Wikberg JES. PLS modeling of chimeric MS04/MSH-peptide and MC1/MC3-receptor interactions reveals a novel method for the analysis of ligand-receptor interactions. Biochim Biophys Acta 2001;1544: 350-357.
33. Pogozheva ID, Chai BX, Lomize AL, Fong TM, Weinberg DH, Nargund RP, Mulholland MW, Gantz I, Mosberg HI. Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists. Biochemistry 2005;44:11329-11341.
34. Yang Y, Fong TM, Dickinson CJ, Mao C, Li JY, Tota MR, Mosley R, Van der Ploeg LHT, Gantz I. Molecular determinants of ligand binding to the human melanocortin-4 receptor. Biochemistry 2000;39:14900-14911.
35. Chai BX, Pogozheva ID, Lai YM, Li JY, Neubig RR, Mosberg HI, Gantz I. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors. Biochemistry 2005;44:3418-3431.